Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2020 | Individualizing RCC treatment

Martin Voss, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses updates on the progression towards individualizing therapy for metastatic renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter